Oncobiomix Adopts AI-Based Disease Insights Platform for Prostate Cancer Test
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read MorePosted by Andy Lundin | Feb 20, 2024 | Prostate |
Oncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read MorePosted by Andy Lundin | Jan 22, 2024 | Prostate |
A new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read MorePosted by Andy Lundin | Jan 10, 2024 | Prostate |
Researchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Prostate |
ArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read MorePosted by Chris Wolski | Dec 26, 2023 | Prostate |
UCLA Researchers have received a five-year, $3 million grant to develop AI that can detect and predict aggressive prostate cancer.
Read More